Herbert Timothy P. 4/A
4/A · Inspire Medical Systems, Inc. · Filed Apr 3, 2024
Insider Transaction Report
Form 4/AAmended
Herbert Timothy P.
DirectorCEO and President
Transactions
- Sale
Common Stock
2024-04-01$203.33/sh−9,388$1,908,862→ 94,270 total(indirect: By Trust) - Sale
Common Stock
2024-04-01$204.35/sh−10,694$2,185,319→ 83,576 total(indirect: By Trust) - Sale
Common Stock
2024-04-01$205.27/sh−11,645$2,390,369→ 71,931 total(indirect: By Trust) - Sale
Common Stock
2024-04-01$206.19/sh−3,379$696,716→ 68,552 total(indirect: By Trust) - Sale
Common Stock
2024-04-01$207.25/sh−1,420$294,295→ 67,132 total(indirect: By Trust) - Sale
Common Stock
2024-04-01$208.34/sh−1,492$310,843→ 65,640 total(indirect: By Trust) - Sale
Common Stock
2024-04-01$209.46/sh−1,310$274,393→ 64,330 total(indirect: By Trust) - Sale
Common Stock
2024-04-01$210.99/sh−232$48,950→ 64,098 total(indirect: By Trust) - Sale
Common Stock
2024-04-01$213.26/sh−440$93,834→ 63,658 total(indirect: By Trust)
Holdings
- 9,690
Common Stock
- 117,658(indirect: By LLC)
Common Stock
- 115,731(indirect: By Trust)
Common Stock
Footnotes (12)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $202.785 to $203.78. The Reporting Person undertakes to provide Inspire Medical Systems, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F10]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $213.03 to $213.99. The Reporting Person undertakes to provide Inspire Medical Systems, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F11]Securities held by the TPH 2022 LLC.
- [F12]Securities held by the Timothy P. Herbert 2013 Family Irrevocable GST Trust U/A/D November 27, 2013.
- [F2]Securities held by the Timothy P. Herbert 2018 Family Continuation Trust c/u the Timothy P. Herbert 2018 Grantor Retained Annuity Trust.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $203.785 to $204.78. The Reporting Person undertakes to provide Inspire Medical Systems, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $204.80 to $205.78. The Reporting Person undertakes to provide Inspire Medical Systems, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F5]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $205.80 to $206.775. The Reporting Person undertakes to provide Inspire Medical Systems, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F6]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $206.825 to $207.79. The Reporting Person undertakes to provide Inspire Medical Systems, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F7]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $207.885 to $208.80. The Reporting Person undertakes to provide Inspire Medical Systems, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F8]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $209.19 to $209.76. The Reporting Person undertakes to provide Inspire Medical Systems, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F9]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $210.935 to $211.06. The Reporting Person undertakes to provide Inspire Medical Systems, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.